Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Restructuring Costs (2024 - 2025)

Palisade Bio has reported Restructuring Costs over the past 3 years, most recently at $3.6 million for Q4 2025.

  • Quarterly Restructuring Costs rose 158.13% to $3.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.6 million through Dec 2025, up 38.37% year-over-year, with the annual reading at $7.6 million for FY2025, 38.37% up from the prior year.
  • Restructuring Costs was $3.6 million for Q4 2025 at Palisade Bio, up from $1.5 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $3.6 million in Q4 2025 and troughed at $1.1 million in Q2 2025.